Aug 12, 2025 6:22 pm
The hype around the off-label use of the immunosuppressant rapamycin to prevent aging and increase longevity could be unfounded.
This is the warning of researchers who have critically explored published human trials, analyses and biomarker modeling to assess whether low-dose rapamycin can indeed help extend healthspan or lifespan in healthy adults.
https://www.newsweek.com/anti-aging-rapamycin-off-label-study-2110873